Ameriprise Financial Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 46,467 shares of RVPH stock, worth $72,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,467Holding current value
$72,953% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$2.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.17 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$2.14 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.66 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$807,4080.13% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $32.1M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...